{"id":50287,"date":"2020-03-24T14:20:24","date_gmt":"2020-03-24T12:20:24","guid":{"rendered":"https:\/\/blog.cofb.cat\/?p=50287"},"modified":"2020-03-24T14:20:24","modified_gmt":"2020-03-24T12:20:24","slug":"migranya-libuprofen-als-biologics","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2020\/03\/24\/migranya-libuprofen-als-biologics\/","title":{"rendered":"Migranya: de l&#8217;ibuprof\u00e8n als biol\u00f2gics"},"content":{"rendered":"<p>El passat <strong>3 de mar\u00e7<\/strong> es va celebrar al COFB la jornada\u00a0<strong>&#8220;Migranya, de l&#8217;ibuprof\u00e8n als biol\u00f2gics&#8221;<\/strong>,<strong>\u00a0<\/strong>que va estar coordinada per <strong>Cristina Roure<\/strong>, vocal d&#8217;Hospitals del COFB; <strong>Roser Vall\u00e8s<\/strong>, vocal d&#8217;Atenci\u00f3 Prim\u00e0ria del COFB -que va ser l&#8217;encarregada de presentar-la- i <strong>Aina Surroca<\/strong>, vocal de la Junta de Govern i responsable de la Comissi\u00f3 Delegada de Formaci\u00f3 continuada del Col\u00b7legi.<\/p>\n<figure id=\"attachment_50469\" aria-describedby=\"caption-attachment-50469\" style=\"width: 620px\" class=\"wp-caption aligncenter\"><a href=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2020\/03\/cofb.200303-07.jpg\"><img fetchpriority=\"high\" decoding=\"async\" class=\"wp-image-50469 size-large\" title=\"Roser Vall\u00e8s, vocal d'Atenci\u00f3 Prim\u00e0ria del COFB, en un moment de la sessi\u00f3.\" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2020\/03\/cofb.200303-07-1024x683.jpg\" alt=\"Roser Vall\u00e8s, vocal d'Atenci\u00f3 Prim\u00e0ria del COFB, en un moment de la sessi\u00f3.\" width=\"620\" height=\"414\" \/><\/a><figcaption id=\"caption-attachment-50469\" class=\"wp-caption-text\">Roser Vall\u00e8s, vocal d&#8217;Atenci\u00f3 Prim\u00e0ria del COFB, en un moment de la sessi\u00f3.<\/figcaption><\/figure>\n<p>La <strong>formaci\u00f3<\/strong>, que va comptar amb <strong>presentacions te\u00f2riques<\/strong> combinades amb <strong>exposici\u00f3<\/strong> i <strong>resoluci\u00f3 de casos pr\u00e0ctics<\/strong>, va estar impartida per: <strong>Merc\u00e8 Barau<\/strong>, farmac\u00e8utica comunit\u00e0ria, membre del grup d&#8217;atenci\u00f3 farmac\u00e8utica del COFB; <strong>Robert Belv\u00eds<\/strong>, neur\u00f2leg, responsable de la Unitat de Cefalees i Neur\u00e0lgies de l&#8217;Hospital de Sant Pau i secretari del Grup d&#8217;Estudi de Cefalees de la Societat Espanyola de Neurologia; <strong>M. Carme Gisbert<\/strong>, metgessa del CAP Vilassar de Dalt, membre del grup de recerca i estudi de cefalees en atenci\u00f3 prim\u00e0ria de la CAMFiC i <strong>Patr\u00edcia Marrero<\/strong>, farmac\u00e8utica especialista en farm\u00e0cia hospital\u00e0ria, de la Unitat de Coordinaci\u00f3 i Estrat\u00e8gia del Medicament de l&#8217;Institut Catal\u00e0 de la Salut.<\/p>\n<h1><span style=\"color: #008080;\"><strong>Quins objectius tenia la jornada?<\/strong><\/span><\/h1>\n<ul>\n<li>Entrar en la <strong>situaci\u00f3 cl\u00ednica de la migranya<\/strong> i saber com afecta la <strong>qualitat de vida<\/strong> del pacient que la pateix.<\/li>\n<li>Con\u00e8ixer <strong>quin abordatge terap\u00e8utic t\u00e9<\/strong>, com s\u2019ha de gestionar i les <strong>mesures higi\u00e8niques i diet\u00e8tiques<\/strong> que han de seguir els pacients.<\/li>\n<li>Saber <strong>quan prescriure el tractament preventiu convencional<\/strong> i <strong>quan el biol\u00f2gic<\/strong>.<\/li>\n<li>Entendre l\u2019<strong>evid\u00e8ncia terap\u00e8utica<\/strong> de tots els <strong>tractaments<\/strong>.<\/li>\n<\/ul>\n<h1><span style=\"color: #008080;\"><strong>Desenvolupament de la sessi\u00f3<\/strong><\/span><\/h1>\n<h3><strong>Situaci\u00f3 cl\u00ednica de la migranya<\/strong><\/h3>\n<p>El neur\u00f2leg Robert Belv\u00eds va abordar la <strong>situaci\u00f3 cl\u00ednica de la migranya<\/strong>: <strong>fisiopatologia<\/strong>, <strong>etiologia<\/strong>, <strong>factors de risc<\/strong>, <strong>tipus<\/strong>, <strong>difer\u00e8ncia entre mal de cap i migranya<\/strong>,<strong> signes i s\u00edmptomes d&#8217;alarma<\/strong>, i la <strong>import\u00e0ncia de la malaltia<\/strong> i l&#8217;<strong>afectaci\u00f3 de la qualitat de vida<\/strong>.<\/p>\n<p>Belv\u00eds va apuntar que la causa de la migranya pot ser <strong>prim\u00e0ria<\/strong>\u00a0-la cefalea \u00e9s la malaltia- o <strong>secund\u00e0ria<\/strong>\u00a0-la cefalea \u00e9s un s\u00edmptoma d&#8217;una malaltia-. Tamb\u00e9 va repassar\u00a0alguns dels <strong>factors cronificants<\/strong> d&#8217;aquesta com: l&#8217;increment dels atacs, esdeveniments estressants vitals, obesitat, depressi\u00f3\/ansietat, ab\u00fas d&#8217;excitants\/alcohol, trastorns del son, hist\u00f2ria d&#8217;ab\u00fas a la inf\u00e0ncia o altres malalties amb dolor.<\/p>\n<figure id=\"attachment_50501\" aria-describedby=\"caption-attachment-50501\" style=\"width: 620px\" class=\"wp-caption aligncenter\"><a href=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2020\/03\/cofb.200303-23.jpg\"><img decoding=\"async\" class=\"wp-image-50501 size-large\" title=\"El Dr. Robert Belv\u00eds, neur\u00f2leg, responsable de la Unitat de Cefalees i Neur\u00e0lgies de l'Hospital de Sant Pau, en un moment de la seva intervenci\u00f3. \" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2020\/03\/cofb.200303-23-1024x683.jpg\" alt=\"El Dr. Robert Belv\u00eds, neur\u00f2leg, responsable de la Unitat de Cefalees i Neur\u00e0lgies de l'Hospital de Sant Pau, en un moment de la seva intervenci\u00f3. \" width=\"620\" height=\"414\" \/><\/a><figcaption id=\"caption-attachment-50501\" class=\"wp-caption-text\">El Dr. Robert Belv\u00eds, neur\u00f2leg, responsable de la Unitat de Cefalees i Neur\u00e0lgies de l&#8217;Hospital de Sant Pau, en un moment de la seva intervenci\u00f3.<\/figcaption><\/figure>\n<h3><strong>Abordatge a l&#8217;atenci\u00f3 prim\u00e0ria i comunit\u00e0ria<\/strong><\/h3>\n<p>Seguidament, la Dra. M. Carme Gisbert va exposar l&#8217;<strong>abordatge de la migranya<\/strong> des de l&#8217;\u00e0mbit de l&#8217;<strong>atenci\u00f3 prim\u00e0ria<\/strong> i <strong>comunit\u00e0ria<\/strong>. Dins d&#8217;aquest punt, va parlar del <strong>ventall terap\u00e8utic<\/strong> del <strong>tractament simptom\u00e0tic<\/strong>, la <strong>gesti\u00f3 inicial de migranyes no complicades<\/strong> i <strong>situacions d&#8217;ab\u00fas<\/strong> i<strong> les mesures higi\u00e8niques<\/strong>, <strong>diet\u00e8tiques<\/strong> i d&#8217;<strong>h\u00e0bits de vida<\/strong>.<\/p>\n<figure id=\"attachment_50503\" aria-describedby=\"caption-attachment-50503\" style=\"width: 620px\" class=\"wp-caption aligncenter\"><a href=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2020\/03\/cofb.200303-16.jpg\"><img decoding=\"async\" class=\"wp-image-50503 size-large\" title=\"La Dra. M. Carme Gisbert, metgessa del CAP Vilassar de Dalt (ICS), membre del grup de recerca i estudi de cefalees en atenci\u00f3 prim\u00e0ria de la CAMFiC.\" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2020\/03\/cofb.200303-16-1024x683.jpg\" alt=\"La Dra. M. Carme Gisbert, metgessa del CAP Vilassar de Dalt (ICS), membre del grup de recerca i estudi de cefalees en atenci\u00f3 prim\u00e0ria de la CAMFiC.\" width=\"620\" height=\"414\" \/><\/a><figcaption id=\"caption-attachment-50503\" class=\"wp-caption-text\">La Dra. M. Carme Gisbert, metgessa del CAP Vilassar de Dalt (ICS), membre del grup de recerca i estudi de cefalees en atenci\u00f3 prim\u00e0ria de la CAMFiC.<\/figcaption><\/figure>\n<p>Finalment, tamb\u00e9 va donar a con\u00e8ixer una <strong>s\u00e8rie de<\/strong> <strong>recomanacions per prevenir la migranya<\/strong> com: aprendre i prendre decisions sobre l&#8217;autocura, confiar amb els professionals de la salut, buscar un patr\u00f3 regular i feli\u00e7 de vida (dormir b\u00e9, alimentar-se correctament, sortir amb els amics, etc.), <strong>manejar els tractaments cronificadors<\/strong> (abordar l&#8217;ansietat i la depressi\u00f3 amb ter\u00e0pies cognitives-conductuals i abordar trastorns del son) i acudir al neur\u00f2leg per valorar l&#8217;efic\u00e0cia de nous tractaments.<\/p>\n<div class=\"box success\"><\/p>\n<p>Per <strong>tractar la migranya<\/strong> \u00e9s fonamental <strong>controlar-ne els factors desencadenants<\/strong>, aquells <strong>relacionats amb la cronificaci\u00f3<\/strong>, l\u2019<strong>adequaci\u00f3 del tractament simptom\u00e0tic a les crisis<\/strong> i, si \u00e9s el cas, <strong>establir un tractament preventiu<\/strong>.\u00a0Les <strong>guies de pr\u00e0ctica cl\u00ednica<\/strong> recomanen <strong>aplicar el tractament preventiu a situacions en qu\u00e8 la freq\u00fc\u00e8ncia afecta considerablement la qualitat de vida de la persona<\/strong>. Els <strong>anticossos monoclonals<\/strong> autoritzats per tractar preventivament la migranya d\u2019adults amb un m\u00ednim de quatre dies de migranya al mes s\u00f3n una classe terap\u00e8utica nova.<\/p>\n<p>Durant la jornada, es va exposar <strong>quina \u00e9s la situaci\u00f3 cl\u00ednica actual de la migranya<\/strong>, com <strong>abordar els diferents nivells assistencials<\/strong> i <strong>quina evid\u00e8ncia terap\u00e8utica tenim dels tractaments simptom\u00e0tics i preventius<\/strong>.<\/p>\n<p><\/div>\n<h3><strong>Tractament preventiu actual (no biol\u00f2gic) i futur (biol\u00f2gic)<\/strong><\/h3>\n<p>D&#8217;altra banda, Robert Belv\u00eds va referir-se a <strong>tres escenaris<\/strong>: migranya epis\u00f2dica de <strong>baixa freq\u00fc\u00e8ncia<\/strong>, migranya epis\u00f2dica d&#8217;<strong>alta freq\u00fc\u00e8ncia<\/strong> i migranya<strong> cr\u00f2nica<\/strong>.<\/p>\n<p>Els <strong>principis del tractament preventiu<\/strong> impliquen controlar els <strong>factors precipitants dels atacs<\/strong>, controlar els <strong>factors de cronificaci\u00f3<\/strong>, revisar les <strong>comorbiditats<\/strong> i <strong>revisar el tractament<\/strong>.<\/p>\n<p>Algunes de les mesures que va oferir Belv\u00eds relacionades amb el <strong>tractament dels factors precipitants<\/strong> van ser: reduir, eliminar i gestionar l&#8217;estr\u00e8s, dormir 8 hores de bona qualitat, regularitzar la menstruaci\u00f3, fer 3 ingestes d&#8217;aliments al dia amb un horari regular, practicar activitat aer\u00f2bica moderada 3 vegades a la setmana i per un per\u00edode superior als 30 minuts, eliminar aliments clarament inductors de migranya i regularitzar el pes.<\/p>\n<h3><strong>Evid\u00e8ncia terap\u00e8utica dels tractaments (preventiu i agut)<\/strong><\/h3>\n<p>Patricia Marrero, farmac\u00e8utica especialista en farm\u00e0cia hospital\u00e0ria, de la Unitat de Coordinaci\u00f3 i Estrat\u00e8gia del Medicament de l&#8217;Institut Catal\u00e0 de la Salut (ICS) va abordar les diferents <strong>guies per a la investigaci\u00f3<\/strong> del <strong>tractament de la migranya<\/strong>, l&#8217;<strong>evid\u00e8ncia<\/strong> dels <strong>f\u00e0rmacs per al tractament agut<\/strong>, l&#8217;<strong>evid\u00e8ncia<\/strong> dels <strong>f\u00e0rmacs per al tractament preventiu<\/strong> i la <strong>situaci\u00f3 actual<\/strong> dels <strong>tractaments preventius<\/strong>.<\/p>\n<figure id=\"attachment_50471\" aria-describedby=\"caption-attachment-50471\" style=\"width: 620px\" class=\"wp-caption aligncenter\"><a href=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2020\/03\/cofb.200303-19.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-50471 size-large\" title=\"Patr\u00edcia Marrero, en un moment de la seva intervenci\u00f3. \" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2020\/03\/cofb.200303-19-1024x683.jpg\" alt=\"Patr\u00edcia Marrero, en un moment de la seva intervenci\u00f3. \" width=\"620\" height=\"414\" \/><\/a><figcaption id=\"caption-attachment-50471\" class=\"wp-caption-text\">Patr\u00edcia Marrero, en un moment de la seva intervenci\u00f3.<\/figcaption><\/figure>\n<h3><strong>Casos pr\u00e0ctics a la farm\u00e0cia comunit\u00e0ria<\/strong><\/h3>\n<p>Durant la darrera part de la sessi\u00f3, la <strong>farmac\u00e8utica Merc\u00e8 Barau<\/strong> va presentar alguns <strong>casos cl\u00ednics<\/strong> i va fer refer\u00e8ncia a la <strong>dosi d&#8217;ibuprof\u00e8n recomanada<\/strong> per al <strong>tractament del dolor lleu o moderat i la inflamaci\u00f3 <\/strong>(que \u00e9s de <strong>400 mg<\/strong>, fins a tres vegades al dia).\u00a0Tamb\u00e9 va aportar algunes <strong>dades de prevalen\u00e7a de la migranya<\/strong>.<strong>\u00a0<\/strong>A l&#8217;Estat espanyol, la <strong>prevalen\u00e7a<\/strong> est\u00e0 al voltant\u00a0del <strong>13% de la poblaci\u00f3<\/strong>, un <strong>7%<\/strong> per als <strong>homes<\/strong> i un <strong>16%<\/strong> per a les <strong>dones<\/strong>.<\/p>\n<p>S&#8217;estima que <strong>la meitat dels pacients amb migranya s&#8217;automediquen<\/strong> i fins a un <strong>40% dels pacients <\/strong>estan <strong>sense diagnosticar<\/strong>. Barau tamb\u00e9 va destacar que<strong> nom\u00e9s un 17% dels pacients utilitza la medicaci\u00f3 correcta <\/strong>per al <strong>tractament simptom\u00e0tic<\/strong> de les <strong>crisis migranyoses<\/strong>.\u00a0D&#8217;altra banda, tamb\u00e9 va repassar <strong>quan cal derivar a urg\u00e8ncies<\/strong> davant d&#8217;un cas de migranya i va recordar que la <strong>cefalea<\/strong> requereix un <strong>adequat diagn\u00f2stic m\u00e8dic<\/strong> i un <strong>tractament prec\u00eds<\/strong>.<\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-align: right;\"><strong>Amb el patrocini de:<\/strong><\/p>\n<p style=\"text-align: right;\"><a href=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2020\/03\/Lilly-i-Novartis.png\"><img loading=\"lazy\" decoding=\"async\" class=\" wp-image-50289 alignright\" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2020\/03\/Lilly-i-Novartis.png\" alt=\"\" width=\"307\" height=\"64\" \/><\/a><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Altres publicacions d&#8217;inter\u00e8s:<\/strong><\/p>\n<ul>\n<li><a href=\"https:\/\/blog.cofb.cat\/antibiotics-nou-objectiu-campanya-sobre-importancia-recepta-medica\/\" target=\"_blank\" rel=\"noopener\">Els antibi\u00f2tics, nou objectiu de la campanya sobre la import\u00e0ncia de la recepta m\u00e8dica (Desembre 2019)<\/a><\/li>\n<li><a href=\"https:\/\/blog.cofb.cat\/botox-noves-indicacions-en-migranya-cronica-i-incontinencia-urinaria\/\" target=\"_blank\" rel=\"noopener\">Botox\u00ae: noves indicacions en migranya cr\u00f2nica i incontin\u00e8ncia urin\u00e0ria (Desembre 2014)<\/a><\/li>\n<li><a href=\"https:\/\/blog.cofb.cat\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/\" target=\"_blank\" rel=\"noopener\">Actualitzaci\u00f3 del tractament terap\u00e8utic de la migranya, tema principal del nou n\u00famero de Circular Farmac\u00e8utica (Juliol 2014)<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>El passat 3 de mar\u00e7 es va celebrar al COFB la jornada\u00a0&#8220;Migranya, de l&#8217;ibuprof\u00e8n als biol\u00f2gics&#8221;,\u00a0que va estar coordinada per Cristina Roure, vocal d&#8217;Hospitals del COFB; Roser Vall\u00e8s, vocal d&#8217;Atenci\u00f3 Prim\u00e0ria del COFB -que va ser l&#8217;encarregada de presentar-la- i Aina Surroca, vocal de la Junta de Govern i responsable [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":50501,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[23,57],"tags":[64,2929,4027,3455,18,356,19,4028,53,68,69,70,3379,3477,4029,335,45,230,4030,76,865,4031,4032,63,4033],"class_list":["post-50287","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-destacats","category-mon-collegial","tag-atencio-farmaceutica","tag-biologics","tag-campanya-sobre-lus-de-la-recepta-medica","tag-casos-practics","tag-cofb","tag-collegi","tag-collegi-de-farmaceutics-de-barcelona","tag-evidencia-terapeutica","tag-farmaceutics","tag-farmacia","tag-farmacia-comunitaria","tag-formacio","tag-ibuprofen","tag-indicacio-farmaceutica","tag-mal-de-cap","tag-medicacio","tag-medicaments","tag-migranya","tag-migranya-cronica","tag-oficina-de-farmacia","tag-recepta-medica","tag-signes-i-simptomes","tag-situacio-clinica-actual","tag-tractament","tag-tractament-preventiu"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Migranya: de l&#039;ibuprof\u00e8n als biol\u00f2gics - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2020\/03\/24\/migranya-libuprofen-als-biologics\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Migranya: de l&#039;ibuprof\u00e8n als biol\u00f2gics - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"El passat 3 de mar\u00e7 es va celebrar al COFB la jornada\u00a0&#8220;Migranya, de l&#8217;ibuprof\u00e8n als biol\u00f2gics&#8221;,\u00a0que va estar coordinada per Cristina Roure, vocal d&#8217;Hospitals del COFB; Roser Vall\u00e8s, vocal d&#8217;Atenci\u00f3 Prim\u00e0ria del COFB -que va ser l&#8217;encarregada de presentar-la- i Aina Surroca, vocal de la Junta de Govern i responsable [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2020\/03\/24\/migranya-libuprofen-als-biologics\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2020-03-24T12:20:24+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2020\/03\/24\/migranya-libuprofen-als-biologics\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2020\/03\/24\/migranya-libuprofen-als-biologics\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Migranya: de l&#8217;ibuprof\u00e8n als biol\u00f2gics\",\"datePublished\":\"2020-03-24T12:20:24+00:00\",\"dateModified\":\"2020-03-24T12:20:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2020\/03\/24\/migranya-libuprofen-als-biologics\/\"},\"wordCount\":1250,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2020\/03\/24\/migranya-libuprofen-als-biologics\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"Atenci\u00f3 farmac\u00e8utica\",\"biol\u00f2gics\",\"campanya sobre l'\u00fas de la recepta m\u00e8dica\",\"casos pr\u00e0ctics\",\"COFB\",\"Col\u00b7legi\",\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"evid\u00e8ncia terap\u00e8utica\",\"farmac\u00e8utics\",\"Farm\u00e0cia\",\"farm\u00e0cia comunit\u00e0ria\",\"Formaci\u00f3\",\"ibuprof\u00e8n\",\"indicaci\u00f3 farmac\u00e8utica\",\"mal de cap\",\"medicaci\u00f3\",\"medicaments\",\"migranya\",\"migranya cr\u00f2nica\",\"Oficina de farm\u00e0cia\",\"recepta m\u00e8dica\",\"signes i s\u00edmptomes\",\"situaci\u00f3 cl\u00ednica actual\",\"tractament\",\"tractament preventiu\"],\"articleSection\":[\"Destacats\",\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2020\/03\/24\/migranya-libuprofen-als-biologics\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2020\/03\/24\/migranya-libuprofen-als-biologics\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2020\/03\/24\/migranya-libuprofen-als-biologics\/\",\"name\":\"Migranya: de l'ibuprof\u00e8n als biol\u00f2gics - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2020\/03\/24\/migranya-libuprofen-als-biologics\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2020\/03\/24\/migranya-libuprofen-als-biologics\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2020-03-24T12:20:24+00:00\",\"dateModified\":\"2020-03-24T12:20:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2020\/03\/24\/migranya-libuprofen-als-biologics\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2020\/03\/24\/migranya-libuprofen-als-biologics\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/novaorg.cofb.net\/2020\/03\/24\/migranya-libuprofen-als-biologics\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2020\/03\/24\/migranya-libuprofen-als-biologics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Migranya: de l&#8217;ibuprof\u00e8n als biol\u00f2gics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Migranya: de l'ibuprof\u00e8n als biol\u00f2gics - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2020\/03\/24\/migranya-libuprofen-als-biologics\/","og_locale":"ca_ES","og_type":"article","og_title":"Migranya: de l'ibuprof\u00e8n als biol\u00f2gics - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"El passat 3 de mar\u00e7 es va celebrar al COFB la jornada\u00a0&#8220;Migranya, de l&#8217;ibuprof\u00e8n als biol\u00f2gics&#8221;,\u00a0que va estar coordinada per Cristina Roure, vocal d&#8217;Hospitals del COFB; Roser Vall\u00e8s, vocal d&#8217;Atenci\u00f3 Prim\u00e0ria del COFB -que va ser l&#8217;encarregada de presentar-la- i Aina Surroca, vocal de la Junta de Govern i responsable [&hellip;]","og_url":"https:\/\/novaorg.cofb.net\/2020\/03\/24\/migranya-libuprofen-als-biologics\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2020-03-24T12:20:24+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"6 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2020\/03\/24\/migranya-libuprofen-als-biologics\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2020\/03\/24\/migranya-libuprofen-als-biologics\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Migranya: de l&#8217;ibuprof\u00e8n als biol\u00f2gics","datePublished":"2020-03-24T12:20:24+00:00","dateModified":"2020-03-24T12:20:24+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2020\/03\/24\/migranya-libuprofen-als-biologics\/"},"wordCount":1250,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2020\/03\/24\/migranya-libuprofen-als-biologics\/#primaryimage"},"thumbnailUrl":"","keywords":["Atenci\u00f3 farmac\u00e8utica","biol\u00f2gics","campanya sobre l'\u00fas de la recepta m\u00e8dica","casos pr\u00e0ctics","COFB","Col\u00b7legi","Col\u00b7legi de Farmac\u00e8utics de Barcelona","evid\u00e8ncia terap\u00e8utica","farmac\u00e8utics","Farm\u00e0cia","farm\u00e0cia comunit\u00e0ria","Formaci\u00f3","ibuprof\u00e8n","indicaci\u00f3 farmac\u00e8utica","mal de cap","medicaci\u00f3","medicaments","migranya","migranya cr\u00f2nica","Oficina de farm\u00e0cia","recepta m\u00e8dica","signes i s\u00edmptomes","situaci\u00f3 cl\u00ednica actual","tractament","tractament preventiu"],"articleSection":["Destacats","M\u00f3n col\u00b7legial"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2020\/03\/24\/migranya-libuprofen-als-biologics\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2020\/03\/24\/migranya-libuprofen-als-biologics\/","url":"https:\/\/novaorg.cofb.net\/2020\/03\/24\/migranya-libuprofen-als-biologics\/","name":"Migranya: de l'ibuprof\u00e8n als biol\u00f2gics - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2020\/03\/24\/migranya-libuprofen-als-biologics\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2020\/03\/24\/migranya-libuprofen-als-biologics\/#primaryimage"},"thumbnailUrl":"","datePublished":"2020-03-24T12:20:24+00:00","dateModified":"2020-03-24T12:20:24+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2020\/03\/24\/migranya-libuprofen-als-biologics\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2020\/03\/24\/migranya-libuprofen-als-biologics\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/novaorg.cofb.net\/2020\/03\/24\/migranya-libuprofen-als-biologics\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2020\/03\/24\/migranya-libuprofen-als-biologics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Migranya: de l&#8217;ibuprof\u00e8n als biol\u00f2gics"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"El passat 3 de mar\u00e7 es va celebrar al COFB la jornada\u00a0&#8220;Migranya, de l&#8217;ibuprof\u00e8n als biol\u00f2gics&#8221;,\u00a0que va estar coordinada per Cristina Roure, vocal d&#8217;Hospitals del COFB; Roser Vall\u00e8s, vocal d&#8217;Atenci\u00f3 Prim\u00e0ria del COFB -que va ser l&#8217;encarregada de presentar-la- i Aina Surroca, vocal de la Junta de Govern i responsable [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/50287","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=50287"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/50287\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=50287"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=50287"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=50287"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}